Kalvista Pharmaceuticals Inc
NASDAQ:KALV

Watchlist Manager
Kalvista Pharmaceuticals Inc Logo
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
Watchlist
Price: 16.9 USD 0.24% Market Closed
Market Cap: 854.3m USD

Wall Street
Price Targets

KALV Price Targets Summary
Kalvista Pharmaceuticals Inc

Wall Street analysts forecast KALV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KALV is 31.62 USD with a low forecast of 22.22 USD and a high forecast of 40.95 USD.

Lowest
Price Target
22.22 USD
31% Upside
Average
Price Target
31.62 USD
87% Upside
Highest
Price Target
40.95 USD
142% Upside
Kalvista Pharmaceuticals Inc Competitors:
Price Targets
IMDX
Insight Molecular Diagnostics Inc
37% Upside
MDXG
MiMedx Group Inc
74% Upside
ADMA
ADMA Biologics Inc
36% Upside
OXB
Oxford BioMedica PLC
17% Upside
SLNO
Soleno Therapeutics Inc
134% Upside
4974
Takara Bio Inc
46% Upside
FOLD
Amicus Therapeutics Inc
70% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
62% Upside

Revenue
Forecast

Revenue Estimate
Kalvista Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Kalvista Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Kalvista Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KALV's stock price target?
Price Target
31.62 USD

According to Wall Street analysts, the average 1-year price target for KALV is 31.62 USD with a low forecast of 22.22 USD and a high forecast of 40.95 USD.

Back to Top